DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Guacetisal
Guacetisal
)&F1y3x PHARMACEUTICAL APPENDIX to THE
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Marrakesh Agreement Establishing the World Trade Organization
WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T
Stembook 2018.Pdf
Inflammation/Immunology
Pharmaceuticals Appendix
FDA-Approved Drug Library Mini (96-Well)
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Customs Tariff - Schedule
(12) Patent Application Publication (10) Pub. No.: US 2017/0071862 A1 WENING Et Al
Osteoarthritis Guideline Appendix 4 – Search Strategies
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 9,358,295 B2 Tygesen Et Al
WO 2015/036470 Al 19 March 2015 (19.03.2015) P O P C T
The Concurrent Initiation of Medications Is Associated With
Top View
JIA Guideline Appendix 4
Harmonized Tariff Schedule of the United States (2006) (Rev
有限公司 Salicylic Acids
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Customs Tariff - Schedule Xxi - 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances 2009
Design, Synthesis, and Antibacterial Study of New Gatifloxacin-Antioxidants As Mutual Prodrugs
Adverse Drug Reactions in Children the Contribution of Off-Label
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Materials
Improved One-Pot Synthesis of Acetylsalol, Benorilate and Guacetisal
JIA Uveitis Guideline Appendix 3
(CD-P-PH/PHO) Report Classification/Justifica
Pharmaceuticals Appendix
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
Pharmaceutical Appendix to the Tariff Schedule 2
Pharmaceutical Compositions Resistant to Abuse